Camp4 Therapeutics CAMP Stock
Camp4 Therapeutics Price Chart
Camp4 Therapeutics CAMP Financial and Trading Overview
| Camp4 Therapeutics stock price | 4.36 USD |
| Previous Close | 4.13 USD |
| Open | 4.17 USD |
| Bid | 3.01 USD x 200 |
| Ask | 5.19 USD x 200 |
| Day's Range | 3.98 - 4.3 USD |
| 52 Week Range | 1.32 - 7.75 USD |
| Volume | 116.07K USD |
| Avg. Volume | 95.27K USD |
| Market Cap | 218.09M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.58 USD |
CAMP Valuation Measures
| Enterprise Value | 121M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.394436 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 55.436794 |
| Price/Book (mrq) | 7.0588226 |
| Enterprise Value/Revenue | 30.758 |
| Enterprise Value/EBITDA | -2.406 |
Trading Information
Camp4 Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 154.54% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 7.75 USD |
| 52 Week Low | 1.32 USD |
| 50-Day Moving Average | 4.3 USD |
| 200-Day Moving Average | 4.26 USD |
CAMP Share Statistics
| Avg. Volume (3 month) | 95.27K USD |
| Avg. Daily Volume (10-Days) | 185.05K USD |
| Shares Outstanding | 51.93M |
| Float | 26.5M |
| Short Ratio | 4.36 |
| % Held by Insiders | 13.06% |
| % Held by Institutions | 86.62% |
| Shares Short | 340.94K |
| Short % of Float | 0.96% |
| Short % of Shares Outstanding | 0.66% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1010.12% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -38.66% |
| Return on Equity (ttm) | -209.28% |
Income Statement
| Revenue (ttm) | 3.93M USD |
| Revenue Per Share (ttm) | 0.1 USD |
| Quarterly Revenue Growth (yoy) | 50.79% |
| Gross Profit (ttm) | -34282000 USD |
| EBITDA | -50294000 USD |
| Net Income Avi to Common (ttm) | -86301000 USD |
| Diluted EPS (ttm) | -2.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 99.21M USD |
| Total Cash Per Share (mrq) | 1.91 USD |
| Total Debt (mrq) | 2.12M USD |
| Total Debt/Equity (mrq) | 6.87 USD |
| Current Ratio (mrq) | 6.148 |
| Book Value Per Share (mrq) | 0.595 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26248000 USD |
| Levered Free Cash Flow (ttm) | -13805000 USD |
Profile of Camp4 Therapeutics
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | One Kendall Square |
| ZIP | 02139 |
| Phone | 617 651 8867 |
| Website | https://www.camp4tx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 48 |
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Q&A For Camp4 Therapeutics Stock
What is a current CAMP stock price?
Camp4 Therapeutics CAMP stock price today per share is 4.36 USD.
How to purchase Camp4 Therapeutics stock?
You can buy CAMP shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Camp4 Therapeutics?
The stock symbol or ticker of Camp4 Therapeutics is CAMP.
Which industry does the Camp4 Therapeutics company belong to?
The Camp4 Therapeutics industry is Biotechnology.
How many shares does Camp4 Therapeutics have in circulation?
The max supply of Camp4 Therapeutics shares is 51.93M.
What is Camp4 Therapeutics Price to Earnings Ratio (PE Ratio)?
Camp4 Therapeutics PE Ratio is now.
What was Camp4 Therapeutics earnings per share over the trailing 12 months (TTM)?
Camp4 Therapeutics EPS is -2.35 USD over the trailing 12 months.
Which sector does the Camp4 Therapeutics company belong to?
The Camp4 Therapeutics sector is Healthcare.
Camp4 Therapeutics CAMP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
US Tech Telecommunications
IXTC
US
|
570.16 USD — |
+0.41
|
— — | 548.06 USD — | 589.35 USD — | — - | — — |
- {{ link.label }} {{link}}